Early destruction of the extracellular matrix around parvalbumin- immunoreactive interneurons in Creutzfeldt-Jakob disease

Neurobiology of Disease

Volumn 6, Issue 4, 1999, Pages 269-279

  Belichenko, Pavel V ^a,b   Miklossy, Judith ^c   Belser, Brigitte ^a   Budka, Herbert ^d   Celio, Marco R ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

^b BRAIN RESEARCH INSTITUTE   (Russian Federation)

^c UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CALCIUM BINDING PROTEIN; PARVALBUMIN; PRION PROTEIN; SIALOGLYCOPROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CREUTZFELDT JAKOB DISEASE; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERNEURON; MALE; NEUROLOGIC DISEASE; PRION DISEASE; PRIORITY JOURNAL;

EID: 0032885694     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1999.0245     Document Type: Article

References (48)

1. Baringer J. R., Bowman K. A., Prusiner S. B. Replication of the scrapie agent in hamster brain precedes neuronal vacuolation. J. Neuropathol. Exp. Neurol. 42:1983;539-547.
2. Belichenko P. V., Miklossy J., Celio M. R. HIV-I induced destruction of neocortical extracellular matrix components in AIDS victims. Neurobiol. Dis. 4:1997;301-310.
3. Bell J. E., Ironside J. W. Neuropathology of spongiform encephalopathies in humans. Br. Med. Bull. 49:1993;738-777.
4. Borchelt D. R., Taraboulos A., Prusiner S. B. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J. Biol. Chem. 267:1992;16188-16199.
5. Brandner S., Isenmann S., Kühne G., Aguzzi A. Identification of the end stage of scrapie using infected neural grafts. Brain Pathol. 8:1998;19-28.
6. Brown D. R., Kretzschmar H. A. Microglia and prion disease: A review. Histol. Histopathol. 12:1997;883-892.
7. Brown D. R., Schmidt B., Kretzschmar H. A. A neurotoxic prion protein fragment enhances proliferation of microglia but not astrocytes in culture. Glia. 18:1996;59-67.
8. Bruce M. E., Will R. G., Ironside J. W., McConnell I., Drummond D., Suttie A., McCardle L., Chree A., Hope J., Birkett C., Cousens S., Fraser H., Bostock C. J. Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature. 389:1997;498-501.
9. Caughey B. Scrapie associated PrP accumulation and its prevention: Insights from cell culture. Br. Med. Bull. 49:1993;860-872.
10. Caughey B. Protease-resistant PrP accumulation and scrapie agent replication: A role for sulphated glycosaminoglycans. Biochem. Soc. Trans. 22:1994a;163-167.
11. Caughey B. Scrapie-associated PrP accumulation and agent replication: Effects of sulphated glycosaminoglycan analogues. Phil. Trans. R. Soc. Lond. B. Biol. Sci. 343:1994b;399-404.
12. Caughey B., Race R. E. Scrapie-associated PrP accumulation and its inhibition: Revisiting the amyloid-glycosaminoglycan connection. Ann. N.Y. Acad. Sci. 724:1994;290-295.
13. Caughey B., Race R. E., Vogel M., Buchmeier M. J., Chesebro B. In vitro expression in eukaryotic cells of a prion protein gene cloned from scrapie-infected mouse brain. Proc. Natl. Acad. Sci. USA. 85:1988;4657-4661.
14. Caughey B., Raymond G. J. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J. Virol. 67:1993;643-650.
15. Celio M. R., Blumcke I. Perineuronal nets - A specialized form of extracellular matrix in the adult nervous system. Brain Res. Rev. 19:1994;128-145.
16. Clinton J., Forsyth C., Royston M. C., Roberts G. W. Synaptic degeneration is the primary neuropathological feature in prion disease: A preliminary study. Neuroreport. 4:1993;65-68.
17. DeArmond S. J., Sanchez H., Yehiely F., Qiu Y., Ninchak-Casey A., Daggett V., Camerino A. P., Cayetano J., Rogers M., Groth D., Torchia M., Tremblay P., Scott M. R., Cohen F. E., Prusiner S. B. Selective neuronal targeting in prion disease. Neuron. 19:1997;1337-1348.
18. DeArmond S. J., Yang S. L., Lee A., Bowler R., Taraboulos A., Groth D., Prusiner S. B. Three scrapie prion isolates exhibit different accumulation patterns of the prion protein scrapie isoform. Proc. Natl. Acad. Sci. USA. 90:1993;6449-6453.
19. Delpech A., Girard N., Delpech B. Localization of hyaluronectin in the nervous system. Brain Res. 245:1982;251-257.
20. Durand-Gorde J. M., Bert J., Nieoullon A. Changes in tyrosine-hydroxilase, glutamic acid decarboxylase and choline acetylcholinesterase after local microinoculation of scrapie agent into the nigrostriatal system of the golden hamster. Brain Res. 341:1985;243-251.
21. Ferrer I., Casas R., Rivera R. Parvalbumin-immunoreactive cortical neurons in Creutzfeldt-Jakob disease. Ann. Neurol. 34:1993;864-866.
22. Fraser H., Dickinson A. G. Distribution of experimentally induced scrapie lesions in the brain. Nature. 216:1967;1310-1311.
23. Goodbrand I. A., Ironside J. W., Nicolson D., Bell J. E. Prion protein accumulation in the spinal cords of patients with sporadic and growth hormone associated Creutzfeldt-Jakob disease. Neurosci. Lett. 183:1995;127-130.
24. Gregoire N., Lebrun F., Fahn L., Salamon G., Nicoli J. A study of GABAergic system in Scrapie-infected hamsters after striatal microinoculation of the agent. Neurosci. Lett. 163:1993;141-144.
25. Guentchev M., Hainfellner J. A., Trabattoni G. R., Budka H. Distribution of parvalbumin-immunoreactive neurons in brain correlates with hippocampal and temporal cortical pathology in Creutzfeldt-Jakob disease. J. Neuropathol. Exp. Neurol. 56:1997;1119-1124.
26. Hayward P. A., Bell J. E., Ironside J. W. Prion protein immunocytochemistry: Reliable protocols for the investigation of Creutzfeldt-Jakob disease. Neuropathol. Appl. Neurobiol. 20:1994;375-383.
27. Haywood A. M. Transmissible spongiform encephalopathies. N. Engl. J. Med. 337:1997;1821-1828.
28. Hecker R., Taraboulos A., Scott M., Pan K. M., Yang S. L., Torchia M., Jendroska K., DeArmond S. J., Prusiner S. B. Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. Genes Dev. 6:1992;1213-1228.
29. Hockfield S., Kalb R. G., Zaremba S., Fryer H. Expression of neural proteoglycans correlates with the acquisition of mature neuronal properties in the mammalian brain. Cold Spring Harbor Symp. Quant. Biol. 55:1990;505-514.
30. Jefferys J. G. R., Empson R. M., Whittington M. A., Prusiner S. B. Scrapie infection of transgenic mice leads to network and intrinsic dysfunction of cortical and hippocampal neurones. Neurobiol. Dis. 1:1994;25-30.
31. Jendroska K., Heinzel F. P., Torchia M., Stowring L., Kretzschmar H. A., Kon A., Stern A., Prusiner S. B., DeArmond S. J. Proteinase-resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity. Neurology. 41:1991;1482-1490.
32. Kretzschmar H. A., Prusiner S. B., Stowring L. E. Scrapie prion proteins are synthesized in neurons. Am. J. Pathol. 122:1986;1-5.
33. Lander C., Kind P., Maleski M., Hockfield S. A family of activity-dependent neuronal cell-surface chondroitin sulfate proteoglycans in cat visual cortex. J. Neurosci. 17:1997;1928-1939.
34. Lu P., Sturman J. A., Bolton D. C. Altered GABA-distribution in hamster brain is an early molecular consequence of infection by scrapie prions. Brain Res. 681:1995;235-241.
35. Manuelidis L., Fritch W., Xi Y. G. Evolution of a strain of CJD that induces BSE-like plaques. Science. 277:1997;94-98.
36. Manuelidis L., Valley S., Manuelidis E. E. Specific proteins associated with Creutzfeldt-Jakob disease and scrapie share antigenic and carbohydrate determinants. Proc. Natl. Acad. Sci. USA. 82:1985;4263-4267.
37. Monari L., Chen S. G., Brown P., Parchi P., Petersen R. B., Mikol J., Gray F., Cortelli P., Montagna P., Ghetti B. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: Different prion proteins determined by a DNA polymorphism. Proc. Natl. Acad. Sci. USA. 91:1994;2839-2842.
38. Mühleisen H., Gehrmann J., Meyermann R. Reactive microglia in Creutzfeldt-Jakob disease. Neuropathol. Appl. Neurobiol. 21:1995;505-517.
39. Parchi P., Castellani R., Capellari S., Ghetti B., Young K., Chen S. G., Farlow M., Dickson D. W., Sima A. A., Trojanowski J. Q., Petersen R. B., Gambetti P. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 39:1996;767-778.
40. Pocchiari M., Masullo C., Lust W. D., Gibbs C. J. J., Gajdusek D. C. Isonicotinic hydrazide causes seizures in scrapie-infected hamsters with shorter latency than in control animals: A possible GABAergic defect. Brain Res. 326:1985;117-123.
41. Priola S. A., Caughey B. Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis. Mol. Neurobiol. 8:1994;113-120.
42. Priola S. A., Caughey B., Raymond G. J., Chesebro B. Prion protein and the scrapie agent: In vitro studies in infected neuroblastoma cells. Infect. Agents Dis. 3:1994;54-58.
43. Quinn M. R., Somerville R. A. Decreased high-affinity binding of [3H]muscimol to cerebral synaptic membranes of scrapie-infected mice. J. Neurochem. 42:1984;290-293.
44. Rieger R., Edenhofer F., Lasmezas C. I., Weiss S. The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nature Med. 3:1997;1383-1388.
45. Sasaki A., Hirato J., Nakazato Y. Immunohistochemical study of microglia in the Creutzfeldt-Jakob diseased brain. Acta Neuropathol. (Berlin). 86:1993;337-344.
46. Taraboulos A., Raeber A. J., Borchelt D. R., Serban D., Prusiner S. B. Synthesis and trafficking of prion proteins in cultured cells. Mol. Biol. Cell. 3:1992;851-863.
47. Taraboulos A., Scott M., Semenov A., Avrahami D., Laszlo L., Prusiner S. B., Avraham D. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J. Cell Biol. 129:1995;121-132.
48. Wiley C. A., Burrola P. G., Buchmeier M. J., Wooddell M. K., Barry R. A., Prusiner S. B., Lampert P. W. Immuno-gold localization of prion filaments in scrapie-infected hamster brains. Lab. Invest. 57:1987;646-656.